CIK 0001637715
- Emerging growth company
OnKure Therapeutics, Inc.
Sign in to watch- Ticker
- OKUR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472309515
- Phone
- +1 720-307-2892
- Business address
- 6707 WINCHESTER CIRCLE, SUITE 400, BOULDER, CO, 80301
- Former names
- Reneo Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,157
- in 2 filings
Net −$1,157. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-21 | Saccomano Nicholas A President and CEO | Sale | −87 | $2.97 | $259 | 11,160 |
| 2026-08-07 | Saccomano Nicholas A President and CEO | Grant or award · Employee Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2026-08-07 | Saccomano Nicholas A President and CEO | Returned to the company · Employee Stock Option (right to buy) | −2,359 | 0 | ||
| 2026-08-07 | Saccomano Nicholas A President and CEO | Grant or award · Employee Stock Option (right to buy) | +2,359 | 2,359 | ||
| 2026-08-07 | Saccomano Nicholas A President and CEO | Returned to the company · Employee Stock Option (right to buy) | −1,485 | 0 | ||
| 2026-08-07 | Saccomano Nicholas A President and CEO | Grant or award · Employee Stock Option (right to buy) | +1,485 | 1,485 | ||
| 2026-08-07 | Saccomano Nicholas A President and CEO | Returned to the company · Employee Stock Option (right to buy) | −8,449 | 0 | ||
| 2026-08-07 | Saccomano Nicholas A President and CEO | Grant or award · Employee Stock Option (right to buy) | +8,449 | 8,449 | ||
| 2026-08-07 | Saccomano Nicholas A President and CEO | Returned to the company · Employee Stock Option (right to buy) | −16,898 | 0 | ||
| 2026-08-07 | Saccomano Nicholas A President and CEO | Grant or award · Employee Stock Option (right to buy) | +16,898 | 16,898 | ||
| 2026-08-07 | Saccomano Nicholas A President and CEO | Returned to the company · Employee Stock Option (right to buy) | −542,232 | 0 | ||
| 2026-08-07 | Saccomano Nicholas A President and CEO | Grant or award · Employee Stock Option (right to buy) | +542,232 | 542,232 | ||
| 2026-06-22 | Saccomano Nicholas A President and CEO | Sale | −86 | $4.40 | $378 | 11,247 |
| 2026-04-01 | Saccomano Nicholas A President and CEO | Grant or award · Employee Stock Option (right to buy) | +330,000 | 330,000 | ||
| 2026-03-23 | Saccomano Nicholas A President and CEO | Sale | −86 | $4.16 | $357 | 7,333 |
| 2025-12-22 | Saccomano Nicholas A President and CEO | Sale | −87 | $2.97 | $258 | 7,419 |
| 2025-09-22 | Saccomano Nicholas A President and CEO | Sale | −88 | $2.62 | $231 | 3,506 |
| 2025-06-23 | Saccomano Nicholas A President and CEO | Sale | −88 | $2.38 | $210 | 3,594 |
| 2025-04-07 | Saccomano Nicholas A President and CEO | Sale | −516 | $2.67 | $1K | 3,682 |
| 2025-04-04 | Saccomano Nicholas A President and CEO | Sale | −358 | $3.33 | $1K | 4,198 |
Page 1 of 2 · 27 trades